Loading stock data…
$70.17-0.46 (-0.65%)
Alcon Inc.
Alcon Inc. in the Healthcare sector is trading at $70.17 with a market capitalization of $30.8B. Wall Street consensus targets $82.73 (16 analysts), implying a +17.9% move over the next 12 months. The stock is currently 20% below its 52-week high of $87.64, remaining 2.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 71 is overbought against a weak tape. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.82B↑ | $2.71B↓ | $2.72B↑ | $2.61B↑ | $2.60B |
| Gross Profit | $1.68B↑ | $1.52B↑ | $1.52B↑ | $1.46B↑ | $1.39B |
| Operating Income | $11.00M↓ | $292.00M↓ | $313.00M↓ | $332.00M↑ | $247.00M |
| Net Income | $0↓ | $189.00M↓ | $217.00M↓ | $237.00M↑ | $176.00M |
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), a...